Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-to-moderate Essential Hypertension”

67 trials

Showing 20 of 67 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06501651
What this trial is testing

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

Who this might be right for
Essential HypertensionType 2 DiabetesNephropathy
Sichuan Academy of Medical Sciences 297
Post-approval studies (Phase 4)UnknownNCT02641821
What this trial is testing

Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension

Who this might be right for
Hypertension
Peking University First Hospital 700
Post-approval studies (Phase 4)Study completedNCT00311155
What this trial is testing

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 694
Large-scale testing (Phase 3)Study completedNCT00257491
What this trial is testing

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 29
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT02177331
What this trial is testing

Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 53
Large-scale testing (Phase 3)Study completedNCT02183701
What this trial is testing

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 715
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Post-approval studies (Phase 4)Study completedNCT00333489
What this trial is testing

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Who this might be right for
Hypertension
Novartis 551
Post-approval studies (Phase 4)Study completedNCT00473174
What this trial is testing

Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension

Who this might be right for
Hypertension
University of Vigo 120
Testing effectiveness (Phase 2)UnknownNCT05033535
What this trial is testing

S086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shenzhen People's Hospital 10
Large-scale testing (Phase 3)Study completedNCT00344110
What this trial is testing

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 768
Large-scale testing (Phase 3)Study completedNCT00856271
What this trial is testing

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 287
Large-scale testing (Phase 3)Study completedNCT01135212
What this trial is testing

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 290
Early research (Phase 1)Study completedNCT00424541
What this trial is testing

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 34
Post-approval studies (Phase 4)Study completedNCT05521282
What this trial is testing

The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension

Who this might be right for
HypertensionMedicine, Chinese Traditional
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 269
Large-scale testing (Phase 3)Study completedNCT00922480
What this trial is testing

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 506
Large-scale testing (Phase 3)Study completedNCT00151827
What this trial is testing

Olmesartan Medoxomil in Hypertension and Renal Impairment

Who this might be right for
Essential HypertensionRenal Impairment
Sankyo Pharma Gmbh 393
Testing effectiveness (Phase 2)Study completedNCT00923611
What this trial is testing

Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 182
Large-scale testing (Phase 3)Study completedNCT00250562
What this trial is testing

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Who this might be right for
Hypertension
Novartis 1,171
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation